Since high eosinophils and plasmacytoid dendritic cells predicted better breast cancer survival in previous research, we speculate that high‐expressed MAL2 might impact the eosinophils and plasmacytoid dendritic cells, which triggered a disadvantageous immune response, leading to poor prognosis in breast cancer. Here, MAL2 is linked to breast carcinoma.